Skip to content

A study for the efficacy of BSL-0051 and BSL-0052 on healthy skin

A study for the efficacy of BSL-0051 and BSL-0052 on healthy skin - A study for the efficacy of BSL-0051 and BSL-0052 on healthy skin

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000024603
Enrollment
10
Registered
2016-11-01
Start date
2016-09-16
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy adults

Interventions

Panelists will apply placebo toner on the both sides of their face twice a day for 1 week. Subsequently panelists will apply placebo toner to one side and BSL-0051- contained toner to another side of

Sponsors

Kao Corporation
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: Panelists who are Japanese males ranging from 20-59 years old.

Exclusion criteria

Exclusion criteria: 1.Panelists with illnesses or diseases which in the opinion of the investigators, might interfere with the conduct of the study or the interpretation of results. Panelists especially with any skin irritation, skin condition (such as rosacea, eczema, atopic dermatitis, or psoriasis), or severe acne on their faces. 2.Panelists who take any supplements, OTC or prescription medications, especially anti-inflammation agents, anti-bacterial agents, analgesic agents, hormonal agents, laxative agents, intestinal agents, etc. 3.Panelists under the care of a doctor taking prescription medication (topical) for any facial skin issues. 4.Panelists with allergy or sensitivity to any facial care product, facial moisturizer, facial cleanser, pore strip, or to any specific ingredient or fragrance used in these types of products. 5.Panelists who refrain from sun exposure, tanning beds, sunless tanners, and skin lightening products until the study completes. 6.Panelists currently participating in, or scheduled to participate in, another facial study during the study period. 7.Panelists having any conditions which in the opinion of the investigators, might interfere with the conduct of the study or the interpretation of results.

Design outcomes

Primary

MeasureTime frame
Evaluation of the sebum content, the sebum composition, the gene expressions, the skin moisture content, the transepidermal water loss and the skin color and the dermatological assessment before and after the application of BSL-0051 and BSL-0052 for 4 weeks.

Countries

Japan

Contacts

Public ContactArisa Katou

Kao Corporation R&D -Core Technology- Biological Science Research

katou.arisa@kao.co.jp0285-68-7498

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026